{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:14:25Z","timestamp":1791976465268,"version":"4.4.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10620-025-09290-7","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T09:41:46Z","timestamp":1753954906000},"page":"3260-3272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vonoprazan Versus Lansoprazole in the Healing and Maintenance Phase of Erosive Esophagitis: A Systematic Review and Meta-Analysis of Randomised Controlled Trials"],"prefix":"10.1007","volume":"70","author":[{"given":"Syed Hasham","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Rayamajhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hareesha Rishab","family":"Bharadwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Gaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhtasim","family":"Fuad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadeep","family":"Dhali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dushyant Singh","family":"Dahiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matan","family":"Bone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushovan","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"9290_CR1","unstructured":"Gastroesophageal Reflux Disease (GERD) - StatPearls - NCBI Bookshelf [Internet]. [cited 2025 Jan 14]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554462\/"},{"key":"9290_CR2","doi-asserted-by":"publisher","first-page":"15249","DOI":"10.1038\/s41598-023-42636-7","volume":"13","author":"AP Witarto","year":"2023","unstructured":"Witarto AP, Witarto BS, Pramudito SL, Ratri LC, Wairooy NAP, Konstantin T et al. Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis. Sci Rep. 2023;13:15249.","journal-title":"Sci Rep."},{"key":"9290_CR3","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2169\/internalmedicine.56.8058","volume":"56","author":"T Ida","year":"2017","unstructured":"Ida T, Inamori M, Inoh Y, Fujita K, Hamanaka J, Chiba H et al. Clinical Characteristics of Severe Erosive Esophagitis among Patients with Erosive Esophagitis: A Case-control Study. Internal Medicine. 2017;56:1293.","journal-title":"Internal Medicine."},{"key":"9290_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/apt.13331","volume":"42","author":"K Ashida","year":"2015","unstructured":"Ashida K, Sakurai Y, Nishimura A, Kudou K, Hiramatsu N, Umegaki E et al. Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis. Aliment Pharmacol Ther. 2015;42:685\u2013695.","journal-title":"Aliment Pharmacol Ther."},{"key":"9290_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1572-0241.2007.01544.x","volume":"103","author":"J Dent","year":"2008","unstructured":"Dent J, Kahrilas PJ, Hatlebakk J, Vakil N, Denison H, Franz\u00e9n S et al. A randomized, comparative trial of a potassium-competitive acid blocker (AZD0865) and esomeprazole for the treatment of patients with nonerosive reflux disease. Am J Gastroenterol. 2008;103:20\u201326.","journal-title":"Am J Gastroenterol."},{"key":"9290_CR6","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.3748\/wjg.v24.i14.1550","volume":"24","author":"K Ashida","year":"2018","unstructured":"Ashida K, Iwakiri K, Hiramatsu N, Sakurai Y, Hori T, Kudou K et al. Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole. WJG. 2018;24:1550\u20131561.","journal-title":"WJG."},{"key":"9290_CR7","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1097\/CM9.0000000000003068","volume":"137","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Qian J, Zhang S, Dai N, Chun HJ, Chiu C et al. Vonoprazan 10 mg or 20 mg vs. lansoprazole 15 mg as maintenance therapy in Asian patients with healed erosive esophagitis: A randomized controlled trial. Chinese Medical Journal. 2024;137:962\u2013971.","journal-title":"Chinese Medical Journal."},{"key":"9290_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"9290_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/jrsm.1373","volume":"10","author":"RK Owen","year":"2019","unstructured":"Owen RK, Bradbury N, Xin Y, Cooper N, Sutton A. MetaInsight: An interactive web-based tool for analyzing, interrogating, and visualizing network meta-analyses using R-shiny and netmeta. Research Synthesis Methods. 2019;10:569.","journal-title":"Research Synthesis Methods."},{"key":"9290_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jclinepi.2023.02.016","volume":"157","author":"CR Nevill","year":"2023","unstructured":"Nevill CR, Cooper NJ, Sutton AJ. A multifaceted graphical display, including treatment ranking, was developed to aid interpretation of network meta-analysis. Journal of Clinical Epidemiology. 2023;157:83\u201391.","journal-title":"Journal of Clinical Epidemiology."},{"key":"9290_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1136\/gutjnl-2019-318365","volume":"69","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Zhang S, Dai N, Fei G, Goh KL, Chun HJ et al. Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis. Gut. 2020;69:224\u2013230.","journal-title":"Gut."},{"key":"9290_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/apt.13461","volume":"43","author":"K Ashida","year":"2016","unstructured":"Ashida K, Sakurai Y, Hori T, Kudou K, Nishimura A, Hiramatsu N et al. Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis. Aliment Pharmacol Ther. 2016;43:240\u2013251.","journal-title":"Aliment Pharmacol Ther."},{"key":"9290_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.08.004","author":"N Uemura","year":"2024","unstructured":"Uemura N, Kinoshita Y, Haruma K, Kushima R, Yao T, Akiyama J et al. Vonoprazan as a Long-term Maintenance Treatment for Erosive Esophagitis: VISION, a 5-Year, Randomized, Open-label Study. Clinical Gastroenterology and Hepatology. 2024. https:\/\/doi.org\/10.1016\/j.cgh.2024.08.004.","journal-title":"Clinical Gastroenterology and Hepatology."},{"key":"9290_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1053\/j.gastro.2022.09.041","volume":"164","author":"L Laine","year":"2023","unstructured":"Laine L, DeVault K, Katz P, Mitev S, Lowe J, Hunt B et al. Vonoprazan Versus Lansoprazole for Healing and Maintenance of Healing of Erosive Esophagitis: A Randomized Trial. Gastroenterology. 2023;164:61\u201371.","journal-title":"Gastroenterology."},{"key":"9290_CR15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s12664-023-01384-2","volume":"42","author":"S Chandan","year":"2023","unstructured":"Chandan S, Deliwala S, Mohan BP et al. Vonoprazan versus lansoprazole in erosive esophagitis\u2014A systematic review and meta-analysis of randomized controlled trials. Indian Journal of Gastroenterology. 2023;42:475\u2013484.","journal-title":"Indian Journal of Gastroenterology."},{"key":"9290_CR16","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/jgh.16486","volume":"39","author":"DM Simadibrata","year":"2024","unstructured":"Simadibrata DM, Lesmana E, Fass R. Vonoprazan is superior to lansoprazole for healing of severe but not mild erosive esophagitis: a systematic review with meta-analysis of randomized controlled trials. Journal of Gastroenterology and Hepatology. 2024;39:988.","journal-title":"Journal of Gastroenterology and Hepatology."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09290-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09290-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09290-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T06:21:45Z","timestamp":1760595705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09290-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["9290"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09290-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No ethics approval needed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}